CN Patent

CN111514147B — 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法

Assigned to Chengdu Xinjie Hi Tech Development Co ltd · Expires 2021-09-17 · 5y expired

What this patent protects

本发明公开了一种用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法,本发明的制剂可以为注射液或干燥粉末,干燥粉末经重建后形成原始溶液,主要用于注射途径给药,本发明药用组合物包含:左西孟旦钠,作为活性成分,以及赋形剂。本发明解决左西孟旦游离碱在水中的不溶解性和上市销售贮藏期间水解降解杂质不稳定问题,使左西孟旦钠可以制备成以水为溶媒的稳定的注射剂。

USPTO Abstract

本发明公开了一种用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法,本发明的制剂可以为注射液或干燥粉末,干燥粉末经重建后形成原始溶液,主要用于注射途径给药,本发明药用组合物包含:左西孟旦钠,作为活性成分,以及赋形剂。本发明解决左西孟旦游离碱在水中的不溶解性和上市销售贮藏期间水解降解杂质不稳定问题,使左西孟旦钠可以制备成以水为溶媒的稳定的注射剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111514147B
Jurisdiction
CN
Classification
Expires
2021-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Xinjie Hi Tech Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.